Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|June 1, 2000
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group InvestigatorsB G Feagan, R N Fedorak, E J Irvine, et al.
Gastroenterology|September 29, 1999
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's diseaseP Rutgeerts, G D'Haens, S Targan, et al.
Alimentary Pharmacology & Therapeutics|May 26, 2018
Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapyW J Sandborn, P Rutgeerts, C Gasink, et al.
Gastroenterology|March 1, 1997
Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591W G Roberts, T J Simon, R G Berlin, et al.
The New England Journal of Medicine|May 6, 1999
Infliximab for the treatment of fistulas in patients with Crohn's diseaseD H Present, P Rutgeerts, S Targan, et al.
Gastroenterology|October 31, 1998
American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12S R Brant, Y Fu, C T Fields, et al.
NMR in Biomedicine|March 5, 2009
Detecting colorectal cancer by 1H magnetic resonance spectroscopy of fecal extractsT Bezabeh, R Somorjai, B Dolenko, et al.
Alimentary Pharmacology & Therapeutics|February 16, 2005
A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's diseaseB G Feagan, W J Sandborn, J P Baker, et al.
Alimentary Pharmacology & Therapeutics|November 22, 2017
Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitisJ-F Colombel, W J Sandborn, W Reinisch, et al.
Gut|April 1, 1997
Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trialR I Breuer, K H Soergel, B A Lashner, et al.
Pageof 13